What is the recommended dosage and treatment plan for using Wellbutrin (bupropion) for smoking cessation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wellbutrin (Bupropion) for Smoking Cessation

Start bupropion SR at 150 mg once daily for 3 days, then increase to 150 mg twice daily (300 mg total daily) for 7-12 weeks, beginning treatment 1-2 weeks before your target quit date. 1, 2

Dosing Protocol

Initiation Phase:

  • Begin bupropion 1-2 weeks prior to the target quit date to establish therapeutic drug levels before the cessation attempt 1, 2
  • Days 1-3: 150 mg orally once daily 1, 2
  • Day 4 onward: 150 mg orally twice daily (if tolerated) 1, 2
  • Maximum dose: 300 mg per day for smoking cessation 1, 2

Treatment Duration:

  • Standard course: 7-12 weeks 1, 2
  • Extended treatment: Can continue for 6 months to 1 year in successful quitters to prevent relapse 1
  • The evidence shows 12-month sustained abstinence rates improve by 9-10 percentage points compared to placebo 3

Monitoring and Follow-Up

Assessment Schedule:

  • Evaluate response after the first 4 weeks of treatment 1
  • Provide an additional month of treatment if the quit attempt is continuing 1
  • Formal efficacy assessment after 7-12 weeks 2

Safety Monitoring:

  • Monitor for neuropsychiatric symptoms including depression, suicidal ideation, or behavioral changes 1
  • Check blood pressure, as bupropion should be avoided in uncontrolled hypertension 2
  • Watch for worsening symptoms in patients younger than 24 years 2

Contraindications and Precautions

Absolute Contraindications:

  • Seizure disorders or any condition that lowers seizure threshold (risk approximately 1 in 1,000) 4, 1, 3
  • Current use of MAO inhibitors or within 14 days of discontinuation 1, 2
  • Patients taking tamoxifen 1
  • Closed-angle glaucoma 1
  • Eating disorders (bulimia or anorexia nervosa) due to increased seizure risk 2
  • Severe hepatic cirrhosis 3

Common Side Effects:

  • Dry mouth (13% vs 5% placebo) 5
  • Insomnia (24% vs 15% placebo) - administer second dose before 3 PM to minimize 2, 5
  • Headaches 1
  • Nausea 1

Rare but Serious Side Effects:

  • Seizures: approximately 1 in 1,000 4, 3
  • Allergic/hypersensitivity reactions: 1 in 1,000 to 1 in 10,000 4, 1

Dose Adjustments for Special Populations

Hepatic Impairment:

  • Moderate to severe impairment: Maximum 150 mg daily (one tablet total) 2

Renal Impairment:

  • Moderate to severe impairment (GFR <90 mL/min): Reduce total daily dose by half 2
  • Bupropion and metabolites are cleared renally and may accumulate 2

Older Adults:

  • Start with 37.5 mg every morning 2
  • Gradually increase by 37.5 mg every 3 days as tolerated 2
  • Maximum dose: 150 mg twice daily (300 mg total) 2

Combination Therapy and Behavioral Support

Pharmacotherapy Combinations:

  • Bupropion can be combined with nicotine replacement therapy (NRT), though evidence for superior efficacy is mixed 1, 6
  • One study showed 69% abstinence at 6 months and 58.6% at one year when combining bupropion with nicotine patches 6

Behavioral Support:

  • Combining pharmacotherapy with behavioral support significantly increases cessation rates 1
  • Include social support, practical problem-solving skills training, and multiple counseling sessions 1
  • Published trials demonstrating efficacy included smokers receiving frequent behavioral counseling sessions 4

Special Clinical Considerations

Depression Comorbidity:

  • Bupropion may be particularly beneficial for smokers with a history of depression, addressing both conditions simultaneously 1, 2
  • The efficacy in smoking cessation appears independent of its antidepressant effect 4

Weight Gain Mitigation:

  • Among continuously abstinent subjects, weight gain was inversely associated with bupropion dose (1.5 kg gain at 300 mg vs 2.9 kg with placebo) 7
  • Combining bupropion with naltrexone can help mitigate smoking cessation-associated weight gain 2

Common Pitfalls to Avoid

  • Don't start too close to quit date: Beginning only days before quitting doesn't allow therapeutic levels to establish 1, 2
  • Don't exceed maximum dose: Never exceed 300 mg/day for smoking cessation to minimize seizure risk 1, 2
  • Don't skip the titration: The gradual increase from 150 mg once daily to twice daily is necessary to minimize seizure risk 2
  • Don't ignore screening: Always screen for seizure risk factors, eating disorders, and medication interactions before prescribing 1, 2, 3

References

Guideline

Bupropion Treatment for Smoking Cessation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bupropion SR for smoking cessation.

Expert opinion on pharmacotherapy, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.